Glycogen storage disease type I: indications for liver and/or kidney transplantation

Eur J Pediatr. 2002 Oct;161 Suppl 1:S53-5. doi: 10.1007/s00431-002-1004-y. Epub 2002 Jul 19.

Abstract

Even though significant progress has been achieved in the management of patients with glycogen storage disease type I, hepatic (mainly adenomas) and renal (proteinuria, renal failure) complications may still develop. Orthotopic liver transplantation has been reported in less than 20 patients, and, in most cases, its indications were multiple hepatic adenomas, sometimes combined with poor metabolic control and/or growth retardation. Even though short-term outcome seems to be favourable, long-term complications have been reported in several cases. Thus it appears that improved metabolic control has to be attempted before performing liver transplantation in such patients. As for renal transplantation, it has been performed in patients with terminal renal failure. It is hoped that improving long-term metabolic control will prevent renal involvement from evolving to terminal renal failure. Finally, combined liver and kidney transplantation may be indicated in a few patients.

Conclusion: organ (liver/kidney) transplantation in glycogen storage disease type I may be advantageous when long-term metabolic control has been attempted. Nevertheless, post-transplantat long-term complications may still develop.

Publication types

  • Review

MeSH terms

  • Glycogen Storage Disease Type I / complications*
  • Glycogen Storage Disease Type I / surgery*
  • Humans
  • Kidney Diseases / etiology
  • Kidney Diseases / surgery*
  • Kidney Transplantation*
  • Liver Diseases / etiology
  • Liver Diseases / surgery*
  • Liver Transplantation*
  • Treatment Outcome